Seeking Alpha

Analysts at both KeyBank and Suntrust move off their Buy ratings on Tempur-Pedic (TPX -46.7%)...

Analysts at both KeyBank and Suntrust move off their Buy ratings on Tempur-Pedic (TPX -46.7%) after admitting they were blindsided by the company's guidance bombshell. To give credit where credit is due, last week channel checks by Barclays tipped off that a problem could be in the making.
Comments (1)
  • Placebo Investment Advice
    , contributor
    Comments (3465) | Send Message
     
    Don't forget that an analyst at Raymond James upgraded Tempurpedic to Strong Buy on May 10th. Most analysts seem to be echo chambers for the self-serving prophesies of corporate executives.

     

    Clearly many Wall Street firms still have too many employees and could use some more layoffs to boost their own margins. They might consider starting with analysts who embarrass themselves and their corporate overlords with upgrades like these.
    6 Jun 2012, 02:02 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs